The levels of CD45 lymphocytes, interleukin-17 (IL-17), interferon-G (IFN-G), and interleukin-6 (IL-6) in CSF and blood of patients with AD are significantly increased [66], suggesting that activated immune cells can also participate in the immune response by entering the brain from the periphery. The gene discussed is IL17A; the disease is Alzheimer disease.